BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs3825942
,
NEUROG3
,
Metabolism of xenobiotics
,
Arthritis
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclo trp- asp- pro- val- leu
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for cyclo trp- asp- pro- val- leu
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of Captopril and BQ123 Endothelin-1 Antagonist on Experimentally Induced Hyperlipidemic Nephr…
Attenuation of opioid tolerance by ETA receptor antagonist, BQ123, administered intravenously in mic…
Effect and Mechanism of Endothelin Receptor A Inhibitor BQ-123 Combined with Electroacupuncture on T…
Treatment With Endothelin-A Receptor Antagonist BQ123 Attenuates Acute Inflammation in Mice Through …
ETA receptors are involved in the febrile response induced by high dose of bacterial endotoxin.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes
Role of Endothelin-1 in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy …
Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ